FDA Requests Label Change for Sleep Disorder Drugs




Natural Standard Podcast show

Summary: The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products strengthen their product labeling to include stronger language concerning potential risks. For more information on integrative therapies visit www.naturalstandard.com.